These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 26702876)
1. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response. Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876 [TBL] [Abstract][Full Text] [Related]
2. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin. Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413 [TBL] [Abstract][Full Text] [Related]
3. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions. Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728 [TBL] [Abstract][Full Text] [Related]
4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
5. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin. Hau CS; Kanda N; Noda S; Tatsuta A; Kamata M; Shibata S; Asano Y; Sato S; Watanabe S; Tada Y Am J Pathol; 2013 May; 182(5):1705-17. PubMed ID: 23499548 [TBL] [Abstract][Full Text] [Related]
6. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice. Bai S; Zhang Z; Hou S; Liu X Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314 [TBL] [Abstract][Full Text] [Related]
7. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice. Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073 [TBL] [Abstract][Full Text] [Related]
8. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses. Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437 [TBL] [Abstract][Full Text] [Related]
9. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related]
10. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice. Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model. Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414 [TBL] [Abstract][Full Text] [Related]
12. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis. Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis. Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859 [TBL] [Abstract][Full Text] [Related]
14. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression. Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod. Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343 [TBL] [Abstract][Full Text] [Related]
16. The vitamin D Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055 [TBL] [Abstract][Full Text] [Related]
17. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
18. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation. Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258 [TBL] [Abstract][Full Text] [Related]
19. Increased Lipocalin-2 Contributes to the Pathogenesis of Psoriasis by Modulating Neutrophil Chemotaxis and Cytokine Secretion. Shao S; Cao T; Jin L; Li B; Fang H; Zhang J; Zhang Y; Hu J; Wang G J Invest Dermatol; 2016 Jul; 136(7):1418-1428. PubMed ID: 26979478 [TBL] [Abstract][Full Text] [Related]